Table 1.1.
Demographic, clinical and neuroimaging variables between the 2019 and the 2020 groups.
| Variables | 2019 (N=301) | 2020 (N=293) | P Value |
|---|---|---|---|
| Age (average ± SD) | 72 ± 15.5 | 70 ± 14.6 | .4 |
| Gender (% female) | 51.2% | 46.1% | .2 |
| First evaluation (%): Spoke Intra-hospital ER |
202 (67,1%) 9 90 |
132 8 153 (52,2%) |
<.01 |
| ASPECTS* (%): High (>6) Low (≤6) |
245 (95,3%) 12 (4,7%) |
225 (90%) 25 (10%) |
.02 |
| Collateral circulation: Good Intermediate Poor |
82 153 21 |
85 138 25 |
.5 |
| Initial NIHSS†: High (>6) Low (≤6) |
215 57 |
210 51 |
.74 |
| Change in NIHSS†: Improvement Stable Worsening |
110 18 21 |
91 19 19 |
.79 |
| Stent deployment(%) | 46 (15.3%) | 53 (18.1%) | .37 |
| Tandem occlusion (%) | 37 (12.4%) | 39 (13.5%) | .73 |
| mTICI‡: good–bad (%) | 260 (87,5%)-37 | 258 (89,6%)-30 | .5 |
| Intravenous fibrinolysis (%) | 111 (36.9%) | 90 (31%) | .14 |
⁎
ASPECTS: Alberta Stroke Programme Early CT Score
†
NIHSS: National Institutes of Health Stroke Scale
‡
mTICI: modified treatment in cerebral ischemia.